High incidence of cytokine release syndrome in patients with advanced NSCLC treated with nivolumab plus ipilimumab
Yoshimasa Shiraishi, Yuta Sekino, Hidehito Horinouchi, Yuichiro Ohe, Isamu Okamoto
Topics & Concepts
MedicineNivolumabIpilimumabPembrolizumabInternal medicineLung cancerPneumonitisOncologyChemotherapyCancerSurgeryImmunotherapyLungCancer Immunotherapy and BiomarkersAcute Lymphoblastic Leukemia researchLung Cancer Treatments and Mutations